Cantor Fitzgerald Starts ArriVent BioPharma (AVBP) at Overweight

December 22, 2025 4:05 PM EST Send to a Friend
(Updated - December 22, 2025 4:05 PM EST)

Cantor Fitzgerald analyst Li Watsek initiates coverage on ArriVent BioPharma (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login